Commission Implementing Regulation (EU) 2024/1749 of 24 June 2024 renewing the approval of the active substance metconazole as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Article 2Amendments to Implementing Regulation (EU) No 540/2011
In force · version of Jul 15, 2024
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.